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Abstract We performed a hospital-acquired methicillin-resistant Staphylococcus aureus molecular study in
Buenos Aires city. Four clones were found harboring the transposable elements Tn4001 and Tn5405
and the erythromycin resistance determinants ermA and mef(E). Of the isolates, 73% belonged to a clone found
previously in the city of Córdoba, which showed an epidemic behavior initially attributed to the widely disseminated
South American clone.
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Resumen La caracterización molecular de aislamientos de Staphylococcus aureus meticilino-resistente
revela la diseminación de un nuevo clon en la ciudad de Buenos Aires. Realizamos un estudio
molecular en aislamientos de Staphylococcus aureus adquiridos en el ambiente hospitalario de la ciudad de
Buenos Aires. Se hallaron cuatro clones que albergaban los elementos transponibles Tn4001 y Tn5405 y los
determinantes de resistencia a eritromicina, ermA y mef(E). El 73% de los aislamientos pertenecían a un clon
hallado previamente en la ciudad de Córdoba con características epidemiológicas atribuidas inicialmente al clon
sudamericano ampliamente diseminado en el mundo.
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Staphylococcus aureus (SA) is a microorganism of
remarkable clinical importance due to the wide variety of
infections observed in nosocomial as non-nosocomial
environments. In Argentina, the percentage of the hospi-
tal-acquired methicillin-resistant SA (HA-MRSA) strains
during 2002 was 52%, according to a report from the
Antibiotic Resistance Informatic System (SIR), a national
health network composed by 22 hospitals. This report also
showed that SA was the most prevalent species acquired
in our hospitals (21%).
Among all the HA-MRSA epidemic clones described
so far, the Iberian and the South American clones have
spread extensively1, 2 and the New York/Japanese clone
has been disseminating in Brazil in the last years3. The
South American clone was prevalent among the HA-
MRSA isolates in Argentina since the 62.2% of them
showed its characteristic PFGE (pulsed-field gel electro-
phoresis) pattern according to a previous report dated in
19984. This pattern was related to resistance to a wide
range of antibiotics like β-lactams, tetracyclines,
aminoglycosides, macrolides, quinolones, trimethoprim-
sulfamethoxazole, and chloramphenicol2. Moreover, the
emergence of a vancomycin and teicoplanin resistant
subpopulation among the South American clone-related
MRSA strains, has been noticed in Brazil recently5.
In 2002, researchers from Córdoba City (located at
798 km from Buenos Aires city), found the South Ameri-
can epidemic clone only in 34% of the isolates and iden-
tified a novel prevalent clone also with epidemic features
in  38% of the isolates6. This new clone differed from the
MRSA South American clone in that was susceptible to
minocycline and trimethoprim-sulfamethoxazole6.
In regard of the mechanisms of resistance, a limited
number of aminoglycoside, and macrolide resistance genes
have been described in Gram positive cocci: aac(6')-
aph(2’), aph(3’)-IIIa, aadE7, 8, erm genes, msrA, mef(A),
vgaA and vgaB9 frequently carried in transposons such as
Tn4001 or Tn5405 (aac(6')-aph(2’), aph(3’)-IIIa, aadE)7,10.
The purpose of this study was to perform a molecular
surveillance of HA-MRSA clones from five hospitals of
Buenos Aires city with the aim to analyze the spreading
of prevalent multiple resistant genotypes. We also deter-
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TABLE 1.– MRSA isolates collected for this study at H1 hospital in August 2000
Isolate n0 Antibiotype1 PCR Antibiotic treatment PFGE6
Resistance- pattern
type2
1 a 1 1.Ciprofloxacin2.Vancomicin A1
2 b 1 Vancomicin C1
3 a 1 Vancomicin A3
4 b 2 Vancomicin plus gentamicin D1
53 a 1 1.Ciprofloxacin plus gentamicin2.Vancomicin A4
6 a 1 1.Cefalotin plus gentamicin2.Teicoplanin A1
7 a 1 Not determined. A5
8 b 1 Teicoplanin C2
9 b 1 Teicoplanin B
10 a 1 1.Ceftazidime, amikacin and metronidazol2.Vancomicin A2
113 b 2 Vancomicin plus rifampicin D2
1 a: Rifampicin, trimethoprim/sulfamethoxazole, tetracycline, minocycline, vancomycin and teicoplanin susceptible; oxacillin, gentamicin,
erythromycin, ciprofloxacin, and clindamicin resistant; b: vancomycin and teicoplanin susceptible; oxacillin, gentamicin, erythromycin,
ciprofloxacin, minocycline, rifampin, trimethoprim/sulfamethoxazole, clindamicin and tetracycline resistant.
2 1: aac(6’)-aph(2’’); aph(3’)-IIIa; aadE; erm(A); sat4; mecA and mef(E); 2: idem 1 but absence of  mef(E);
3 Patients dead by sepsis due to staphylococcal infection.
4 Outpatient 7 was hospitalized before in H1a.
5 1: corresponds to the first antimicrobial treatment choice, and 2 corresponds to the second antimicrobial treatment choice.
6 PFGE: pulsed-field gel electrophoresis.
TABLE 2.– Characteristics of MRSA isolates collected
in September 2003.
Isolate n0 Hospital Antibiotype1 PFGE2pattern
12 H1 c A1
13,  14, 16, 17 H1 a A1
15 H1 a A1
18-20 H1 a A3
21-25 H2 a A1
26-27 H3 a A1
28,29 H3 b B
30 H4 a A2
31 H4 a A1
32 H4 b C2
33 H4 b B
34 H5 a A3
35 H5 a A3
36-37 H5 a A3
1 a: Rifampicin, trimethoprim/sulfamethoxazole, tetracycline, minocycline,
vancomycin and teicoplanin susceptible; oxacillin, gentamicin,
erythromycin, ciprofloxacin, and clindamicin resistant; b: vancomycin and
teicoplanin susceptible; oxacillin, gentamicin, erythromycin, minocycline,
ciprofloxacin, rifampicin, trimethoprim/sulfametoxazole, clindamicin and
tetracycline resistant; c: trimethoprim/sulfamethoxazole, minocycline,
vancomycin and teicoplanin susceptible; oxacillin, gentamicin, rifampicin,
erythromycin, ciprofloxacin, clindamicin and tetracycline resistant.
2 PFGE: pulsed-field gel electrophoresis
mined the mechanisms of resistance involved in some of
the MRSA isolated from hospital H1 in the first window
period (Table 1).
We performed two one-month molecular surveillances
of HA-MRSA epidemiologically unrelated isolates during
August 2000 (n=11) from hospital H1 and September 2003
(n=26) from five hospitals including H1 (n=9) (Tables 1
and 2) in Buenos Aires city. All MRSA isolates (n=37) were
collected from inpatients with different types of infections
(Tables 1 and 2). In the hospital H1, the samples were
isolated from two buildings that are separated 3 miles from
each other (H1a and H1b) that share several nurses and
medical staff as well as patients. However, the patients
from our study have never been at the two hospital centers
before this study. All strains collected were grown in brain-
heart infusion agar with 5% sheep blood and incubated at
37 °C during 24 hs in a 5% CO2 atmosphere.
The susceptibility to a wide variety of antibiotics was
determined by the Kirby & Bauer method according to
the NCCLS guidelines11 using S. aureus strain 25923 as
control10. Genomic DNA was extracted by the guanidinium
thiocyanate method12. The presence of mecA, aac(6’)-
aph(2’’), aph(3’)-IIIa, ant(4’)-Ia, aadA, aadE, mef(A),
mef(E), msrA, erm(A), erm(B), erm(C), erm(M), erm(TR),
Tn4001, Tn5405 and the insertion sequences IS256,
IS1181and IS1182, was determined by the standard PCR
technique. All the PCRs were carried out as previously
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described8, 13 using primers designed in our laboratory or
by others7, 13 and automated nucleotide sequence analy-
sis was performed.
PFGE with enzyme SmaI was used for the clonal char-
acterization of the 37 MRSA isolates using the CHEF DR-
III system (BioRad, Hercules, Calif.). Percent similarity
was estimated by the simple matching coefficient, and
the matrix was clustered by the unweight pair group
method (UPMGA). In this study, the analysis was per-
formed as previously described13; an 80% similarity level
was considered, corresponding to differences in 7 bands.
The 37 MRSA isolates showed 10 different patterns,
which were grouped in 4 clusters (A, B, C, and D, Figures
1A and B). The difference in the number of bands among
the clusters varied between 8 and 12 bands and between
2 and 5 within the same cluster. The prevalent cluster
(A), was identified as the Córdoba city epidemic clone
(73% of the isolates) that showed the antibiotype a with
the exception of one isolate that showed antibiotype c
(isolate 12, table 2), while the other clones B, C and D
(the first recognized as the South American clone)
harbored a more resistant antibiotype (antibiotype b, Ta-
ble 1). The antibiotype a showed susceptibility to rifampin,
trimethoprim-sulfamethoxazole, tetracycline, minocycline,
vancomycin and teicoplanin, the antibiotype b was only
susceptible to vancomycin and teicoplanin and the
antibiotype c was susceptible to rifampin, minocycline,
trimethoprim-sulfamethoxazole, vancomycin and teico-
planin. The molecular resistance profile analysis of the
Córdoba city clone, showed the presence of the loci
aac(6’)-aph(2’’), aph(3’)-IIIa, aadE and sat4 (resistance
to streptothricin). Two PCR products of 1.5 kb each (right
and left junctions) and one of 1.1 kb (IS256) confirmed
the presence of Tn4001 and the DNA sequence showed
Fig. 1A.– PFGE patterns of SmaI digested genomic DNA of the 11 MRSA strains
isolated from H1 in 2000. L: phage lambda concatemers used as molecular marker.
The dendogram shows the four clones or clusters in the MRSA population. The
arrow indicates the cut off used to differ the clusters.
Fig. 1B.– PFGE patterns of SmaI digested genomic DNA of the three clones and
subtypes. The dendogram shows the three clones or clusters of the MRSA strains
isolated from H1, H2, H3, H4 and H5 during the period 2003. The arrow indicates
the cut off used to differ the clusters. See also Table 2.
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100% homology with this element. The PCR to detect
IS1181, IS1182, aadE and aph(3’)-IIIa sequences ren-
dered amplification products of 1.2 kb (IS1181), 1.1 kb
(IS1182), 3.6 kb (IS1182-aadE), 5.7 kb (IS1182-aph(3’)-
IIIa) and 2.2 kb (aadE-aph(3’)-IIIa) that, by nucleotide
sequence analysis, belonged to the complete structure
of the Tn5405. Other resistance determinants detected
by PCR in these clones were erm(A)(645pb), mef(A)
(316pb) and mef(E)(513 pb) (Table 1).
The percentage of isolation of MRSA strains in our
hospitals remained the same (55%), since 1996 when
the South American clone was predominant4. Our results
suggest that since 2000, the South American clone is not
having an epidemic behavior in Buenos Aires city, and
that the clone from Córdoba city is taking its niche. In Ar-
gentina, the dissemination of resistance genes has been
increasing in the last decade4, 14. Although several works
have focused on epidemiological surveys of MRSA2, 15, to
our knowledge, this is the first study where the antimicro-
bial determinants as well as the clonal spreading have been
evaluated at the same time in a molecular surveillance.
The emergence of a novel epidemic clone of MRSA in
our hospitals denotes that although the spreading of a
MRSA clone may be limited, it does not imply the eradi-
cation of this species in the hospital environment. In re-
gard of MRSA, the molecular identification of virulence
factors could be helpful to identify the reason of the pre-
dominance of this clone over another because the spread-
ing of an epidemic clone can be explained not only by
selective antibiotic pressure but also by its ability to sur-
vive within the nosocomial environment and colonize pa-
tients and hospital personnel.
It can be concluded that it is necessary to perform a
continuously molecular and epidemiological surveillance
system to detect rapid changes that modify the genotype
and the resistance profile of HA-MRSA clones with epi-
demic behavior. Such studies would help to evaluate
control infection policies with the aim to reduce the inci-
dence of infections caused by MRSA isolates.
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